Alice Garnier

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

Gandhi Damaj, Alain Duhamel, Marie Robin et al. · Journal of Clinical Oncology · 2012 · 204 citations · Full text

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé et al. · Blood Advances · 2019 · 120 citations · Full text

Tumour lysis syndrome and acute kidney injury in high‐risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en <scp>R</scp>éanimation Respiratoire et <scp>O</scp>nco‐<scp>H</scp>ématologique

Michaël Darmon, François Vincent, Laurent Camous et al. · British Journal of Haematology · 2013 · 105 citations

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

Thierry Guillaume, Florent Malard, Léonardo Magro et al. · Bone Marrow Transplantation · 2019 · 96 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +9

Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Amandine Le Bourgeois, Marianne Coste‐Burel, Thierry Guillaume et al. · JAMA Network Open · 2021 · 65 citations · Full text